US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

FRX

Ferrex (FRX)

Ferrex

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:FRX

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/07/19	20 : 30	RNS Non-Regulatory	Keras Resources PLC Update regarding Investor Presentation and GM	LSE:FRX	Ferrex
2022/06/22	23 : 20	RNS Non-Regulatory	Keras Resources PLC New Date - Shareholder/Investor Presentation	LSE:FRX	Ferrex
2022/06/09	15 : 03	RNS Non-Regulatory	Keras Resources PLC Shareholder/Investor Meeting and Presentation	LSE:FRX	Ferrex
2021/06/24	22 : 36	RNS Non-Regulatory	Keras Resources PLC Updated Corporate Presentation	LSE:FRX	Ferrex
2019/10/30	16 : 00	RNS Non-Regulatory	Keras Resources PLC Joint Investor Event - Further Details	LSE:FRX	Ferrex
2018/09/14	20 : 00	RNS Non-Regulatory	Keras Resources PLC Investor Event	LSE:FRX	Ferrex
2017/11/24	00 : 55	RNS Non-Regulatory	Keras Resources PLC New Company Presentation	LSE:FRX	Ferrex
2017/11/16	18 : 47	RNS Non-Regulatory	Keras Resources PLC Pilbara Gold Presentation-London 23 November 2017	LSE:FRX	Ferrex
2017/08/01	15 : 02	RNS Non-Regulatory	Keras Resources PLC Brandon Hill Research	LSE:FRX	Ferrex
2016/04/12	20 : 20	RNS Non-Regulatory	Keras Resources PLC New Corporate Presentation	LSE:FRX	Ferrex
2016/03/18	16 : 00	RNS Non-Regulatory	Keras Resources PLC Corporate Presentation	LSE:FRX	Ferrex
2009/10/29	18 : 54	Dow Jones News	Richter To Start Late Stage Tests On Key Schizophrenia Drug	NYSE:FRX	Forest Laboratories Inc.
2009/10/29	17 : 47	Dow Jones News	Hungary Richter, US Forest Announce Positive Drug Tests	NYSE:FRX	Forest Laboratories Inc.
2009/08/28	07 : 31	PR Newswire (US)	Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduce	NYSE:FRX
2009/08/19	22 : 50	Dow Jones News	2nd UPDATE: Glenmark, Forest Say Their Drug Failed In Trials	NYSE:FRX	Forest Laboratories Inc.
2009/08/19	16 : 53	Dow Jones News	UPDATE: Glenmark, Forest Say Oglemilast Failed In Key Study	NYSE:FRX	Forest Laboratories Inc.
2009/08/12	17 : 32	Dow Jones News	AstraZeneca, Forest Labs Ink Ceftaroline Deal	NYSE:FRX	Forest Laboratories Inc.
2009/08/10	20 : 00	PR Newswire (US)	Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPD	NYSE:FRX
2009/07/21	22 : 08	Dow Jones News	Forest Labs 1Q Net Up 8.2% As Namenda Sales Jump	NYSE:FRX	Forest Laboratories Inc.
2009/06/22	22 : 20	PR Newswire (US)	Beacon Equity Research on Stocks to Watch: Forest Labs, Harris, Philip Morris, IAMGOLD, Steel Dynamics and Wyndham	NYSE:FRX
2009/06/20	03 : 40	Dow Jones News	Forest Labs Reports Upbeat Pneumonia Drug Test Results	NYSE:FRX	Forest Laboratories Inc.
2009/06/10	23 : 54	Dow Jones News	PHARMA MARKET: Wyeth Stands By Pristiq After Slow Start	NYSE:FRX	Forest Laboratories Inc.
2009/05/23	05 : 34	Dow Jones News	Drug Makers To Pay $89 Million To Settle Alabama Medicaid Price Suits	NYSE:FRX	Forest Laboratories Inc.
2009/05/06	00 : 03	Dow Jones News	2nd UPDATE:Jubilant Organosys Unit In Pact With AstraZeneca	NYSE:FRX	Forest Laboratories Inc.
2009/04/30	17 : 01	Dow Jones News	Almirall, Forest See New Drug Application For COPD By 2012	NYSE:FRX	Forest Laboratories Inc.
2009/04/21	22 : 09	Dow Jones News	Forest Labs 4Q Net Drops 46% Amid Marketing Probe Set-Aside	NYSE:FRX	Forest Laboratories Inc.
2009/04/04	08 : 34	Dow Jones News	UPDATE: FDA Warns World's Largest Drug Firms Over Internet Ads	NYSE:FRX	Forest Laboratories Inc.
2009/04/04	07 : 22	Dow Jones News	FDA Warns World's Largest Drug Firms Over Internet Ads	NYSE:FRX	Forest Laboratories Inc.
2009/03/06	21 : 21	Dow Jones News	FDA Wants More Study On Almirall, Forest Labs COPD Drug	NYSE:FRX	Forest Laboratories Inc.
2009/02/26	07 : 24	Dow Jones News	UPDATE:DOJ:Forest Labs Engaged In Improper Marketing,Kickbacks	NYSE:FRX	Forest Laboratories Inc.

Showing the most relevant articles for your search:LSE:FRX

Invesco QQQ Trust Series 1

BNP Paribas (QX)

Bank of America

Deutsche Telekom (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約